Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc., as indicated in the metadata) on May 11, 2011, reporting events occurring on May 10, 2011. The filing serves to announce the Company's financial results for the first quarter ended March 31, 2011, via a press release attached as Exhibit 99.01.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.01), which is incorporated by reference but not included in the provided text.
Material Changes
No specific material changes versus the prior comparable period are detailed in the text of this Form 8-K. The document solely references the issuance of the Q1 2011 results press release.
Guidance, Outlook, and Risks
The filing includes a standard Regulation FD disclosure and states that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act. No specific guidance, outlook, management commentary, risks, or unusual items are described in the body of this report.
Investor Verification Checklist
- Verify the correct registrant name is Neuralstem, Inc., not Palisade Bio, Inc.
- Review Exhibit 99.01 (Press Release dated May 10, 2011) for actual Q1 2011 financial figures.
- Confirm the reporting period is the quarter ended March 31, 2011.
- Note that this 8-K is a disclosure vehicle and does not contain the detailed financial data itself.